Activity
  • Addressing Pressing Challenges in Life Sciences

    Eliminating silos of data into a comprehensive industrial data fabric enables reshaping the data landscape to provide aggregated, contextualized data for digital transformation initiatives for pharmaceutical & biotech manufacturers. The post Addressing Pressing Challenges in Life Sciences appeared first on the Emerson Automation Experts blog.
  • The Road to Self-Driving Labs Starts with Smarter Automation

    If there’s one thing that has been repeatedly proven true in the life sciences industry, it’s that automation drives success. After all, automation leads to repeatability, fewer mistakes, higher safety, and faster outcomes. This high success rate for automation in life sciences is one of the key reasons many people are talking about the potential […] The post The Road to Self-Driving Labs Starts with Smarter Automation…
  • The Road to Self-Driving Labs Starts with Smarter Automation

    If there’s one thing that has been repeatedly proven true in the life sciences industry, it’s that automation drives success. After all, automation leads to repeatability, fewer mistakes, higher safety, and faster outcomes. This high success rate for automation in life sciences is one of the key reasons many people are talking about the potential […] The post The Road to Self-Driving Labs Starts with Smarter Automation…
  • Award-Winning DeltaV Real-Time Scheduling Software Podcast

    David Zhang joins podcast host Jim Cahill to discuss digitalization efforts among pharmaceutical & biotech manufacturers, and the important role that real-time scheduling plays in bringing these therapies to market in a timely manner. The post Award-Winning DeltaV Real-Time Scheduling Software Podcast appeared first on the Emerson Automation Experts blog.
  • Why Cybersecurity Looks Different in Life Sciences

    We talk a lot about cybersecurity in the OT space. Cybersecurity has always posed a unique challenge for OT technologies, for a number of reasons. Often, OT teams are dealing with legacy technology that was never designed to be cybersecure and doesn’t operate in a manner that plays well with external cybersecurity tools. In addition, […] The post Why Cybersecurity Looks Different in Life Sciences appeared first on the…
  • Driving Innovation and Efficiency in Life Sciences Manufacturing

    The life sciences industry is rapidly advancing with innovations in personalized medicine, digital health, and biopharmaceuticals. To keep up with the demand for quality, speed, and sustainability, manufacturers are adopting automation and digital technologies. Key tools like smart sensors and advanced measurement devices enable real-time monitoring and precise control throughout the manufacturing process, resulting in…
  • Driving Innovation and Efficiency in Life Sciences Manufacturing

    The life sciences industry is rapidly advancing with innovations in personalized medicine, digital health, and biopharmaceuticals. To keep up with the demand for quality, speed, and sustainability, manufacturers are adopting automation and digital technologies. Key tools like smart sensors and advanced measurement devices enable real-time monitoring and precise control throughout the manufacturing process, resulting in…
  • The Golden Age of Life Sciences Innovation Needs Smarter Data

    There exists an interesting tension in the life sciences industry; while people have access to more treatments for more maladies than at any other time in human history, there is also increasing pressure to deliver new, innovative treatments. For evidence, simply look to the massive wave of innovation happening in the personalized medicine space. The […] The post The Golden Age of Life Sciences Innovation Needs Smarter…
  • Seamless Automation for a Personalized Future

    It’s hard to discuss the life sciences today without talking about advanced therapeutics and personalized medicine. We are currently in a period of massive innovation that will reshape the delivery of medicine for decades to come. Where once pharmaceutical companies were laser focused on blockbuster drugs, today they are exploring more targeted therapeutic research that […] The post Seamless Automation for a Personalized…
  • Advancing Life Sciences Automation: Insights from Emerson Exchange 2025

    Highlights on a path to more connected sites, systems, and the enterprise. This Emerson Exchange session featured discussions involving foundational connectivity, module enhancements, a scalable data fabric, integrated applications, and an intelligent platform specific to the Life Sciences sector. The post Advancing Life Sciences Automation: Insights from Emerson Exchange 2025 appeared first on the Emerson Automation…
  • Advancing Life Sciences Automation: Insights from Emerson Exchange 2025

    At the Emerson Exchange 2025 Conference in San Antonio, Texas, Emerson’s Michalle Adkins collected feedback from the Life Sciences team on their Meet the Experts session. The key reminder for participants, customers, Impact Partners, and Emerson subject matter experts was that we are all in this together, working hard to ultimately provide therapies to patients. A technology roadmap was shared, highlighting the path to…
  • Raising the Bar for Flow Measurement: My Conversation on Control Amplified

    Flow measurement may not always make headlines, but for industries like oil and gas, chemical manufacturing, and life sciences, it’s the cornerstone of operational excellence. I recently had the pleasure of joining Len Vermillion on the Control Amplified podcast to talk about how Emerson’s Micro Motion ELITE Coriolis flow meters are redefining what’s possible in this space. Listen to the episode here . Precision That…
  • Sustainability in Life Sciences: How Automation is Driving Carbon Reduction

    Advanced automation technologies offer scalable solutions. These range from wireless acoustic transmitters that detect steam trap leaks in real time to predictive analytics that flag failing batches before they waste precious energy and materials. Even better, many of these tools offer short ROI timelines—sometimes within months. The post Sustainability in Life Sciences: How Automation is Driving Carbon Reduction appeared…
  • Sustainability in Life Sciences: How Automation is Driving Carbon Reduction

    As the global push toward decarbonisation intensifies, the life sciences industry faces the dual challenge of reducing emissions while maintaining the quality and availability of life-saving therapies. The stakes are high—but so are the opportunities. A recent white paper by Emerson explores how automation and digitalisation can help life sciences manufacturers reduce their carbon footprint —without disrupting core…
  • Teams of Life Savers Partnering to Accelerate and Deliver Therapies Podcast

    Manufacturers in the Life Sciences sector are increasingly challenged by the advancement of advanced therapies and personalized medicines, as well as the rapidly advancing technology landscape. Emerson’s Jordan Johnson and Rachel Wright join me to discuss these challenges and the role of Emerson and its “Life Savers,” who work closely with them to address and overcome these challenges. Give the podcast a listen, and…
  • ​​​Solutions for Advanced Therapy Medicinal Products​

    Emerson’s Bruce Greenwald, Christian Berg, and David Gray collaborated to present "Solutions for Advanced Therapeutics" at the Emerson Exchange 2025 Conference. The post ​​​Solutions for Advanced Therapy Medicinal Products​ appeared first on the Emerson Automation Experts blog.
  • ​​​Solutions for Advanced Therapy Medicinal Products​

    Emerson’s Bruce Greenwald , Christian Berg , and David Gray collaborated to present “Solutions for Advanced Therapeutics” at the Emerson Exchange 2025 Conference. Here is their presentation abstract.   ATMPs hold incredible potential to treat and cure life-threatening diseases, but managing the complex operations required for these therapies presents unique challenges. From precise control of patient-specific materials…
  • Unlocking the Potential of Autologous Cell & Gene Therapy Through Digital Transformation

    Autologous and personalized cell and gene therapies (CGTs) are at the frontier of modern medicine, offering potential cures for previously untreatable conditions. However, scaling these therapies presents complex challenges distinct from traditional pharmaceuticals. Manufacturing requires managing multiple small, patient-specific batches, leading to issues such as high costs, time-sensitive processes, and regulatory scrutiny…
  • Unlocking the Potential of Autologous Cell & Gene Therapy Through Digital Transformation

    Autologous and personalised cell and gene therapies (CGTs) represent one of the most promising frontiers in modern medicine offering curative potential for conditions once deemed untreatable. However, realising their full potential at scale remains a complex challenge for life sciences manufacturers. Unlike traditional pharmaceuticals, autologous CGTs require a scale-out approach managing multiple small, patient-specific…
  • Accelerating mRNA Therapy Production with Digital Innovation

    Unlock the future of medicine with scalable mRNA therapies. Overcome production challenges using cutting-edge digital tools from Emerson and AspenTech. Digital twins, process automation, and real-time analytics streamline manufacturing, reduce risks, and ensure regulatory compliance. The post Accelerating mRNA Therapy Production with Digital Innovation appeared first on the Emerson Automation Experts blog.
  • Accelerating mRNA Therapy Production with Digital Innovation

    Messenger RNA (mRNA) therapies are shaping the future of medicine from personalized vaccines to treatments for rare diseases. Yet, producing these therapies at scale remains a significant challenge due to the complexity of manufacturing processes, regulatory hurdles, and the need for precise, high-quality operations. Download our white paper Digital Excellence in Nuclear Acid Therapy to explore how digital tools can support…
  • Unlock the Power of Sustainable & Efficient Measurement Instrumentations in Life Sciences

    In today’s rapidly evolving world, achieving sustainability has become a pivotal goal, especially in industries like life sciences, where energy efficiency and emission reduction are critical. Emerson’s innovative measurement instrumentations are at the forefront of enabling these advancements. Let’s explore how these cutting-edge solutions are helping life sciences industries drive sustainability and operational efficiency…
  • Unlock the Power of Sustainable & Efficient Measurement Instrumentations in Life Sciences

    In today’s rapidly evolving world, achieving sustainability has become a pivotal goal, especially in industries like life sciences, where energy efficiency and emission reduction are critical. Emerson’s innovative measurement instrumentations are at the forefront of enabling these advancements. Let’s explore how these cutting-edge solutions are helping life sciences industries drive sustainability and operational efficiency…
  • Unlocking Value Trapped in OT Data Podcast

    The complexity of operating manufacturing and production facilities continues to grow. Data is abundant but often siloed in many different applications. The need to drive improvements in safety, efficiency, quality and reliability often requires data from these many divergent sources. In this Emerson Automation Experts podcast, Hamza Malik shares a solution to these silos of data, to bring them together to turn data…
  • Managing process knowledge throughout drug development and manufacturing

    Digital transformation can be described as the integration of digital technology to create new business processes to meet changing market requirements. Within the life sciences industry, the market is demanding accelerated development and availability of new therapies. Digital transformation is helping the industry by providing the opportunity to execute tasks throughout the product development chain more efficiently…